Arrowhead Pharmaceuticals, Inc.
ARWR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000879407
In the last 90 days, Arrowhead Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 2 sales; 501 institutions reported holding it in 13F filings for Q2 2026, worth $9.73B in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Arrowhead Pharmaceuticals, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 307
- −1 vs. Q4 2021
- Shares held
- 69.3M
- +1.32M (+1.9%) vs. Q4 2021
- Total value
- $3.19B
- −$1.32B (−29.3%) vs. Q4 2021
- New holders
- 38
- 118 more added
- Sold out
- 39
- 102 more reduced
3 institutions that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARWR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 501 | $9.73B |
| Q1 2026 | 437 | $7.58B |
| Q4 2025 | 401 | $7.70B |
| Q3 2025 | 303 | $3.83B |
| Q2 2025 | 281 | $1.67B |
| Q1 2025 | 264 | $1.34B |
| Q4 2024 | 269 | $1.88B |
| Q3 2024 | 272 | $1.90B |
| Q2 2024 | 272 | $2.54B |
| Q1 2024 | 273 | $2.76B |
| Q4 2023 | 266 | $2.37B |
| Q3 2023 | 257 | $2.01B |
| Q2 2023 | 274 | $2.57B |
| Q1 2023 | 257 | $1.85B |
| Q4 2022 | 282 | $2.97B |
| Q3 2022 | 278 | $2.35B |
| Q2 2022 | 279 | $2.54B |
| Q1 2022 | 307 | $3.19B |
| Q4 2021 | 311 | $4.51B |
| Q3 2021 | 297 | $4.16B |
| Q2 2021 | 314 | $5.54B |
| Q1 2021 | 289 | $4.55B |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Arrowhead Pharmaceuticals, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Invesco Ltd. | 2,334,074 | $107.3M | 0.03% | +28,433+1.2% | Added |
| Alliancebernstein L.P. | 2,756,331 | $126.8M | 0.05% | +291,820+11.8% | Added |
| JPMorgan Chase & Co | 2,920,953 | $134.3M | 0.02% | −58,111−2.0% | Reduced |
| State Street Corp | 4,681,955 | $215.3M | 0.01% | +777,184+19.9% | Added |
| Vanguard Group Inc | 9,718,250 | $446.9M | 0.01% | +78,107+0.8% | Added |
| BlackRock Inc. | 12,155,084 | $559.0M | 0.02% | +147,021+1.2% | Added |
| Sofos Investments, Inc. | 552 | – | – | −306−35.7% | Reduced |
| Proequities, Inc. | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| RTW Investments, LP | 0 | $0 | 0.00% | −346,842−100.0% | Sold out |
| L1 Capital Pty Ltd | 0 | $0 | 0.00% | −292,735−100.0% | Sold out |
| Cetera Investment Advisers | 0 | $0 | 0.00% | −119,565−100.0% | Sold out |
| Castleark Management LLC | 0 | $0 | 0.00% | −76,020−100.0% | Sold out |
| Integral Health Asset Management, LLC | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Lisanti Capital Growth, LLC | 0 | $0 | 0.00% | −33,765−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −33,117−100.0% | Sold out |
| Calamos Advisors LLC | 0 | $0 | 0.00% | −29,571−100.0% | Sold out |
| Echo Street Capital Management LLC | 0 | $0 | 0.00% | −7,961−100.0% | Sold out |
| Donoghue Forlines LLC | 0 | $0 | 0.00% | −7,823−100.0% | Sold out |
| Redwood Investments, LLC | 0 | $0 | 0.00% | −6,193−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −6,090−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −4,916−100.0% | Sold out |
| PEAK6 Investments LLC | 0 | $0 | 0.00% | −4,309−100.0% | Sold out |
| Magnetar Financial LLC | 0 | $0 | 0.00% | −3,936−100.0% | Sold out |
| Coldstream Capital Management Inc | 0 | $0 | 0.00% | −3,604−100.0% | Sold out |
| Pearl River Capital, LLC | 0 | $0 | 0.00% | −3,605−100.0% | Sold out |
| Wedbush Securities Inc | 0 | $0 | 0.00% | −3,360−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −3,330−100.0% | Sold out |
| Wealthspire Advisors, LLC | 0 | $0 | 0.00% | −3,319−100.0% | Sold out |
| Stanley-Laman Group, Ltd. | 0 | $0 | 0.00% | −3,153−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −1,600−100.0% | Sold out |
| IronBridge Private Wealth, LLC | 0 | $0 | 0.00% | −955−100.0% | Sold out |
| First Horizon Advisors, Inc. | 0 | $0 | 0.00% | −912−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −911−100.0% | Sold out |
| Advisors Asset Management, Inc. | 0 | $0 | 0.00% | −370−100.0% | Sold out |
| TFC Financial Management | 0 | $0 | 0.00% | −357−100.0% | Sold out |
| Bank Julius Baer & Co. Ltd, Zurich | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Neo Ivy Capital Management | 0 | $0 | 0.00% | −197−100.0% | Sold out |
| Confluence Wealth Services, Inc. | 0 | $0 | 0.00% | −156−100.0% | Sold out |
| Sageworth Trust Co | 0 | $0 | 0.00% | −115−100.0% | Sold out |
| Spire Wealth Management | 0 | $0 | 0.00% | −101−100.0% | Sold out |
| Smith Group Asset Management, LLC | 0 | $0 | 0.00% | −110−100.0% | Sold out |
| Umb Bank N A | 0 | $0 | 0.00% | −59−100.0% | Sold out |
| Financial Management Professionals, Inc. | 0 | $0 | 0.00% | −21−100.0% | Sold out |
| Concord Wealth Partners | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| Sutton Wealth Advisors Inc. | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Eagle Bay Advisors LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Tygh Capital Management, Inc. | – | – | – | – | Not filed |
| Carroll Financial Associates, Inc. | – | – | – | – | Not filed |
| Bell Investment Advisors, Inc | – | – | – | – | Not filed |